World Diabetes Day is an annual event that takes place on 14th November, with the aim of raising awareness of diabetes. 2019 has been no exception and the Department’s INNODIA team was keen to take part and introduce the study to those visiting Addenbrooke’s Hospital in Cambridge.

INNODIA is a pan-European consortium of researchers, industry partners and patient organisations with the goal “to fight Type 1 Diabetes”. The Department of Paediatrics in the University of Cambridge co-ordinates a longitudinal observational study and aims to recruit 700 more people who have been newly diagnosed with Type 1 Diabetes and 300 family members who are at risk of developing the condition.

If you did not get a chance to speak to our team and would like to find out more about the study, please visit the INNODIA website.

INNODIA is the Innovative Medicines Initiative or IMI-supported European consortium that aims to improve the understanding of type 1 diabetes and is paving the way to novel therapeutic options to prevent and cure this disease. INNODIA will collect throughout Europe blood samples and data from newly diagnosed patients with type 1 diabetes and first degree relatives of people with type 1 diabetes and study the evolution of the disease in these individuals.